Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 440

1.

Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS.

J Gen Intern Med. 2007 Apr;22(4):527-30.

2.

[Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].

Fhima A, Henrion R, Lowenstein W, Charpak Y.

Ann Med Interne (Paris). 2001 Apr;152 Suppl 3:IS26-36. French.

PMID:
11435992
3.

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.

Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, Bertacca S.

Drug Alcohol Depend. 2004 Jul 15;75(1):37-45.

PMID:
15225887
4.

Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.

Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG.

JAMA Intern Med. 2014 Dec;174(12):1947-54. doi: 10.1001/jamainternmed.2014.5302.

PMID:
25330017
5.

Treatment of heroin dependence with buprenorphine in primary care.

Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS.

Am J Drug Alcohol Abuse. 2002;28(2):231-41.

PMID:
12014814
6.

Prescription opioid abuse in patients presenting for methadone maintenance treatment.

Brands B, Blake J, Sproule B, Gourlay D, Busto U.

Drug Alcohol Depend. 2004 Feb 7;73(2):199-207.

PMID:
14725960
7.

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD.

Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8. doi: 10.1016/j.drugalcdep.2012.12.010. Epub 2013 Jan 18.

8.

Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Moratti E, Kashanpour H, Lombardelli T, Maisto M.

Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.

PMID:
20450240
9.

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.

Nielsen S, Hillhouse M, Mooney L, Ang A, Ling W.

J Subst Abuse Treat. 2015 Jan;48(1):70-6. doi: 10.1016/j.jsat.2014.06.006. Epub 2014 Jun 28.

10.

Buprenorphine-containing treatments: place in the management of opioid addiction.

Robinson SE.

CNS Drugs. 2006;20(9):697-712. Review.

PMID:
16953647
11.

Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.

De Ducla M, Gagnon A, Mucchielli A, Robinet S, Vellay A.

Ann Med Interne (Paris). 2000 Oct;151 Suppl B:B9-15.

PMID:
11104938
12.

Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.

Gerra G, Leonardi C, D'Amore A, Strepparola G, Fagetti R, Assi C, Zaimovic A, Lucchini A.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):265-72. Epub 2005 Nov 23.

PMID:
16309810
13.

A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.

Bell J, Shanahan M, Mutch C, Rea F, Ryan A, Batey R, Dunlop A, Winstock A.

Addiction. 2007 Dec;102(12):1899-907. Epub 2007 Sep 3.

PMID:
17784896
14.

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.

PMID:
15450648
15.

Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians.

Coffin PO, Blaney S, Fuller C, Vadnai L, Miller S, Vlahov D.

Am J Drug Alcohol Abuse. 2006;32(1):1-6.

PMID:
16450639
16.

Treating opioid dependence. Growing implications for primary care.

Krantz MJ, Mehler PS.

Arch Intern Med. 2004 Feb 9;164(3):277-88. Review.

PMID:
14769623
17.
18.

Helping 'them': our role in recovery from opioid dependence.

Loxterkamp D.

Ann Fam Med. 2006 Mar-Apr;4(2):168-71.

19.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
20.

Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.

Wang EA, Moore BA, Sullivan LE, Fiellin DA.

J Gen Intern Med. 2010 Jul;25(7):670-4. doi: 10.1007/s11606-010-1306-0. Epub 2010 Mar 6.

Supplemental Content

Support Center